Labcorp Holdings LH Diagnostics — Labor and Related Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Labcorp Holdings in its filing.
Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.
The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Labcorp Holdings's diagnostics — labor and related expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Labcorp Holdings's diagnostics — labor and related expense?
- Labcorp Holdings (LH) reported diagnostics — labor and related expense of $1.19B in Q1 2026.
- How has Labcorp Holdings's diagnostics — labor and related expense changed year-over-year?
- Labcorp Holdings's diagnostics — labor and related expense increased by 5.7% year-over-year, from $1.12B to $1.19B.
- What is the long-term trend for Labcorp Holdings's diagnostics — labor and related expense?
- Over 3 years (2022 to 2025), Labcorp Holdings's diagnostics — labor and related expense has grown at a 8.6% compound annual growth rate (CAGR), from $3.66B to $4.69B.
- What does diagnostics — labor and related expense mean?
- This includes all compensation, benefits, and payroll-related costs for staff directly involved in the diagnostics segment's operations, such as phlebotomists, lab technicians, and support personnel. It is a critical component of the segment's cost structure and operational efficiency.